Serum anti-leukemia inhibitory factor antibody and recurrent pregnancy loss in Iranian women

Seyed Mohammad Seifati , Hossein Ansariniya , Fateme Rahmani , Ali Akbar Saboor-Yaraghi , Farzaneh Fesahat , Hossein Hadinedoushan , Fateme Zare

Asian Pacific Journal of Reproduction ›› 2023, Vol. 12 ›› Issue (1) : 49 -50.

PDF (1009KB)
Asian Pacific Journal of Reproduction ›› 2023, Vol. 12 ›› Issue (1) :49 -50. DOI: 10.4103/2305-0500.365232
Letter To Editor
research-article
Serum anti-leukemia inhibitory factor antibody and recurrent pregnancy loss in Iranian women
Author information +
History +
PDF (1009KB)

Cite this article

Download citation ▾
Seyed Mohammad Seifati, Hossein Ansariniya, Fateme Rahmani, Ali Akbar Saboor-Yaraghi, Farzaneh Fesahat, Hossein Hadinedoushan, Fateme Zare. Serum anti-leukemia inhibitory factor antibody and recurrent pregnancy loss in Iranian women. Asian Pacific Journal of Reproduction, 2023, 12 (1) : 49-50 DOI:10.4103/2305-0500.365232

登录浏览全文

4963

注册一个新账户 忘记密码

Conflict of interest statement

The authors declare that there is no conflict of interest.

Funding

This study received no extramural funding.

Authors’ contributions

Ali Akbar Saboor-Yaraghi carried out the conception and design of the research. Fateme Zare carried out the analysis and interpretation of data. Seyed Mohammad Seifati, Fateme Rahmani, Hossein Hadinedoushan and Farzaneh Fesahat participated in design and coordination and helped to draft the manuscript and revise the manuscript for important intellectual content. The first draft of the manuscript was written by Hossein Ansariniya. All authors read and approved the final manuscript.

References

[1]

Miresmaeili SM, Fesahat F, Kazemi N, Ansariniya H, Zare F. Possible role of leukemia inhibitory factor and inflammatory cytokines in recurrent spontaneous abortion. Int J Fertil Steril 2022 doi: 10.22074/ijfs.2022.548425.1258.

[2]

Zare F, Amiri MM, Hadinedoushan H, Dehghan-Manshadi M, Mansouri F, Fesahat F, et al. Contraceptive and molecular function of a novel recombinant vaccine based human leukemia inhibitory factor on Balb/c mice: An experimental in vivo study. J Reprod Immunol 2020; 142: 103195. doi: 10.1016/j.jri.2020.103195.

[3]

Zare F, Saboor-Yaraghi AA, Hadinedoushan H, Dehghan-Manshadi M, Mirzaei F, Mansouri F, et al. Production and characterization of recombinant human leukemia inhibitory factor and evaluation of antifertility effects of rabbit anti-rhLIF in Balb/c mice. Protein Expres Purif 2020; 174: 105684. doi: 10.1016/j.pep.2020.105684.

[4]

Terakawa J, Wakitani S, Sugiyama M, Inoue N, Ohmori Y, Kiso Y, et al. Embryo implantation is blocked by intraperitoneal injection with anti-LIF antibody in mice. J Reprod Dev 2011; 57(6):700-777. doi: 10.1262/jrd.11-048h.

[5]

White CA, Zhang JG, Salamonsen LA, Baca M, Fairlie WD, Metcalf D, et al. Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: A nonhormonal contraceptive strategy. Proc Natl Acad Sci USA 2007; 104(49):19357-19362. doi: 10.1073/pnas.0710110104.

PDF (1009KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/